Future of EU Biotechnology and Biomanufacturing

by name voted on 10.07.2025

Summary

The resolution calls for strengthening the EU's biotechnology sector through a new 'EU Biotech Act' and streamlined regulations to boost competitiveness and security.

10 10.07.2025

Report

health

economy

science

industry

environment

social policy

public administration

research and intellectual property

Key points

Recognition of biotechnology and biomanufacturing as critical strategic sectors for Europe's competitiveness, sustainability, and security.
The call for a new, cross-sectoral EU Biotech Act to provide a unified regulatory framework and reduce bureaucratic burdens.
A demand to urgently streamline and shorten authorization procedures for products and clinical trials.
The need to address fragmented investment ecosystems by providing better access to venture capital and de-risking instruments for SMEs.

Vote

PPE

S&D

PfE

ECR

Renew

Verts/ALE

The Left

NI

ESN

Total

Documents (PDFs)

DRAFT REPORT on the future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness REPORT on the future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness Future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness Follow up to T10-0165/2025

These raw data are provided by the Open Data Portal of the European Union (data.europa.eu) and are licensed under ODC-BY 1.0.